Financials
- Market Capitalization 1.18 B
- Employee 142
- Founded 2018
- CEO Steve Harr
- Website www.sana.com
- Headquarter Delaware, United States
- FIGI BBG00N5BMH61
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2313 | IMTX Immatics N.V. - Ordinary Shares | 9.43 USD | +0.75% | +5.60% | +8.64% | -8.89% | 1.26 B USD | ||
| 2348 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.16 USD | -3.80% | -1.46% | +5.99% | +161.25% | 1.19 B USD | ||
| 2371 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.38 USD | -6.56% | -6.43% | -39.81% | +18.41% | 1.14 B USD | ||
| 2385 | KURA Kura Oncology, Inc. - Common Stock | 12.66 USD | -3.95% | +7.56% | +36.42% | +55.72% | 1.13 B USD |